The company is substantially boosted its course of a new solution for amyloid heart disease, leveraging Attruby. Initial trial data suggests significant benefits for patients affected by the severe disease. This https://bridgebio736323.blog4youth.com/42663137/company-progresses-amyloidosis-treatment-through-the-drug